Knight, M, Kenyon, S, Brocklehurst, P et al. (eds) on behalf of MBRRACE. Saving Lives, Improving Mothers’ Care – Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–12. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2014.Google Scholar

World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Hemorrhage. Geneva: WHO; 2012.Google Scholar

Kassebaum, NJ, Betozzi-Villa, A, Coggeshall, MS et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 980–1004.CrossRefGoogle ScholarPubMed

American Academy of Family Practitioners (AAFP). Advanced Life Support in Obstetrics. Syllabus Updates; 2008. www.aafp.org/online/en/home/cme/aafpcourses/clinicalcourses/also/syllabus.html#Parsys0003 (accessed May 21 2008).Google Scholar

Ford, JB, Roberts, CL, Simpson, JM, Vaughan, J, Cameron, CA. Increased postpartum hemorrhage rates in Australia. International Journal of Gynecology and Obstetrics 2007; 98: 237–243.CrossRefGoogle ScholarPubMed

Briley, A, Seed, PT, Tydeman, G et al. Reporting errors, incidence and risk factors for postpartum hemorrhage and progression to severe PPH: a prospective observational study. BJOG: An International Journal of Obstetrics and Gynecology 2014; 121(7): 876–888.CrossRefGoogle ScholarPubMed

Scottish Confidential Audit of Severe Maternal Morbidity. Reducing Avoidable Harm. 10th Annual Report. http://www.healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/reproductive_health/scasmm.aspx (accessed June 12 2015).Google Scholar

Magann, EF, Evans, S, Chauhan, SP et al. The length of the third stage of labor and risk of postpartum hemorrhage. Obstetrics and Gynecology 2005; 105(2): 290–293.CrossRefGoogle ScholarPubMed

Department of Health. Why Mothers Die, 1997–1999. The Fifth Annual Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press.Google Scholar

Lewis, G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Why Mothers Die (2000–2002). London: CEMACH; 2005.Google Scholar

Magann, EF, Evans, S, Hutchinson, M et al. Postpartum hemorrhage after cesarean delivery; an analysis of risk factors. South Medical Journal 2005; 98: 681–685.CrossRefGoogle ScholarPubMed

National Institute for Health and Clinical Excellence. NICE Intrapartum Guidelines. CG190; 2014. http://www.nice.org.uk/guidance/cg190/evidence/cg190-intrapartum-care-full-guideline3 (accessed June 12 2015).Google Scholar

Bais, JM, Eskes, M, Pel, M, Bonsel, GJ, Bleker, OP. Postpartum hemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum hemorrhage. European Journal of Obstetrics & Gynecology and Reproduction Biology 2004; 115: 166–172.Google Scholar

Prendiville, WJ, Elbourne, D, McDonald, S. Active versus expectant management of the third stage of labor. Cochrane Database of Systematic Reviews 2000(2): CD00007.Google Scholar

Royal College of Obstetricians and Gynecologists. Clamping of the Umbilical Cord and Placental Transfusion. Scientific Impact Paper No. 14; 2015. https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip-14.pdf (accessed June 12 2015).Google Scholar

World Health Organization. Delayed Umbilical Cord Clamping for Improved Maternal and Infant Health and Nutrition Outcomes; 2014. http://www.who.int/nutrition/publications/guidelines/cord_clamping/en/ Accessed 12/06/2015Google Scholar

Hofmeyr, GJ, Mshweshwe, NT, Gülmezoglu, AM. Controlled cord traction for the third stage of labor. Cochrane Database of Systematic Reviews 2015; (1): CD008020.Google Scholar

Khan, GQ, John, IS, Wani, S et al. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomised controlled trial. American Journal of Obstetrics and Gynecology 1997; 177: 770–774.Google Scholar

Zhao, S, Xiaofeng, S. Clinical study in curing postpartum hemorrhage in the third stage of labor. Journal of Practical Obstetrics and Gynecology 2003; 19: 278–280.Google Scholar

Giacalone, PL, Vignal, J, Daures, JP, et al. A randomised evaluation of two techniques of management of the third stage of labor in women at low risk of postpartum hemorrhage. British Journal of Obstetrics and Gynecology 2000; 107: 396–400.CrossRefGoogle Scholar

Royal College of Obstetricians and Gynecologists. Placenta Previa, Placenta Previa Accreta and Vasa Previa: Diagnosis and Management. Green-Top Guideline No. 27. London: Royal College of Obstetricians and Gynecologists; 2011. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg27/ (accessed June 12 2015).Google Scholar

Confidential Enquiries into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: Reviewing Maternal Deaths to make Motherhood Safer: 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2007.Google Scholar

Mackintosh, N, Watson, K, Rance, S, Sandall, J. Value of a modified early obstetric warning system (MEOWS) in managing maternal complications in the peripartum period: an ethnographic study. BMJ Quality and Safety 2014; 23(1): 26–34.CrossRefGoogle ScholarPubMed

Bick, DE, Sandall, J, Furuta, M et al. A national cross sectional survey of heads of midwifery services of uptake, benefits and barriers to use of obstetric early warning systems (EWS) by midwives. Midwifery 2014; 30(11): 1140–1146.Google Scholar

Su, LL, Chng, YS, Samuel, M. Carbetocin for preventing postpartum hemorrhage. Cochrane Database of Systematic Reviews 2012; (2): CD005457.Google Scholar

Mori, R, Nardin, JM, Yamamoto, N, Carroli, G, Weeks, A. Umbilical vein injection for the routine management of third stage of labor. Cochrane Database of Systematic Reveiws 2012; (3): CD006176.Google Scholar

Knight, M, UKOSS. Peripartum hysterectomy in the UK: management and outcomes of the associated hemorrhage. British Journal of Obstetrics and Gynecology: an International Journal of Obstetrics and Gynecology 2007; 114: 1380–1387.Google Scholar

Furuta, M, Sandall, J, Bick, D. A systematic review of the relationship between severe maternal morbidity and post-traumatic stress disorder. BMC Pregnancy and Childbirth 2012; 12: 125. http://doi: 10.1186/1471–2393-12–125.Google Scholar

Knight, M, Kenyon, S, Brocklehurst, P et al. (eds) on behalf of MBRRACE. Saving Lives, Improving Mothers’ Care – Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–12. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2014.Google Scholar

Healthcare Improvement Scotland. Scottish Confidential Audit Severe Maternal Morbidity 10th Annual Report; 2014. http://www.healthcareimprovementscotland.org/our_work/reproductive,_maternal_child/programme_resources/scasmm.aspx (accessed April 28 2015).Google Scholar

Association of Anesthetists of Great Britain and Ireland; Thomas, D, Wee, M, Clyburn, P et al. Blood transfusion and the anesthetist: management of massive hemorrhage. Anaesthesia 2010; 65(11): 1153–1161.Google Scholar

Draycott, T, Winter, C, Crofts, J, Barnfield, S. Practical Obstetric Multi-professional Training (PROMPT) Trainer’s Manual. London: RCOG Press; 2008.Google Scholar

Crofts, JF, Ellis, D, Draycott, TJ et al. Change in knowledge of midwives and obstetricians following obstetric emergency training: a randomised controlled trial of local hospital, simulation center and teamwork training. BJOG: An International Journal of Obstetrics and Gynecology 2007; 114: 1534–1541.CrossRefGoogle ScholarPubMed

https://www.resus.org.uk/pages/alsABCDE.htm (accessed April 28 2015).Google Scholar

National Institute for Health and Care Excellence. Detecting, Managing and Monitoring Hemostasis: Viscoelastometric Pointofcare Testing (ROTEM, TEG and Sonoclot Systems) Diagnostic Guidance 13: DG13; 2014. http://www.nice.org.uk/guidance/dg13 (Accessed July 13 2015).Google Scholar

Perel, P, Roberts, I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Systematics Reviews 2007; 17: CD000567.Google Scholar

RCOG. Postpartum Hemorrhage, Prevention and Management. Green-Top Guideline No. 52. London: Royal College of Obstetricians and Gynecologists; 2015. https://www.rcog.org.uk/globalassets/documents/guidelines/gt52postpartumhemorrhage0411.pdf (accessed April 28 2015).Google Scholar

Lilley, G, Burkett-St-Laurent, D, Precious, E et al. Measurement of blood loss during postpartum hemorrhage. International Journal of Obstetric Anesthesia 2015; 24(1): 8–14.CrossRefGoogle Scholar

RCOG. Placenta Previa, Placenta Previa Accreta and Vasa Previa: Diagnosis and Management. Green-Top Guideline No. 27. London: Royal College of Obstetricians and Gynecologists; 2015. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_27.pdf (accessed April 28 2015).Google Scholar

Charbit, B, Mandelbrot, L, Samain, E et al. PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 2007; 5(2): 266–273.CrossRefGoogle Scholar

Stainsby, D, MacLennan, S, Thomas, D, Isaac, J, Hamilton, PJ. Guidelines on the management of massive blood loss. British Journal of Haematology 2006; 135: 634–641.Google Scholar

Allard, S, Green, L, Hunt, BJ. How we manage the hematological aspects of major obstetric hemorrhage. British Journal of Haematology 2014; 164(2): 177–188.CrossRefGoogle Scholar

Wikkelsø, AJ, Edwards, HM, Afshari, A et al. FIB-PPH trial group. Pre-emptive treatment with fibrinogen concentrate for postpartum hemorrhage: randomized controlled trial. British Journal of Anaesthesia 2015; 114(4): 623–633.CrossRefGoogle ScholarPubMed

Collins, PW, Cannings-John, R, Bruynseels, D et al.; the OBS2 Study Team. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. British Journal of Anaesthesia 2017; aex181. doi:10.1093/bja/aex181 (accessed July 26 2017).CrossRefGoogle Scholar

World Health Organization. Recommendations for the Prevention and Treatment of Postpartum Hemorrhage. Geneva: WHO; 2012. http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548502/en/ (accessed April 28 2015).Google Scholar

Ducloy-Bouthors, AS, Jude, B, Duhamel, A et al. High-dose tranexamic acid reduces blood loss in postpartum hemorrhage. Critical Care 2011; 15(2): R117.Google Scholar

WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389: 2105–2116.Google Scholar

Lavigne-Lissalde, G, Aya, AG, Mercier, FJ et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. Journal of Thrombosis and Haemostasis 2015; 13(4): 520–529.CrossRefGoogle ScholarPubMed

UK National Institute for Health and Clinical Excellence. Intraoperative Blood Cell Salvage in Obstetrics. IP Guidance Number: IPG144; 2005. http://www.nice.org.uk/guidance (accessed April 28 2015).Google Scholar

Allam, J, Cox, M, Yentis, SM. Cell salvage in obstetrics. International Journal of Obstetric Anesthesia 2008; 17: 37–45.CrossRefGoogle ScholarPubMed

Catling, S, Thomas, D. Intraoperative autologous blood transfusion. In Arulkumaran, S, Karoshi, M, Keith, LG, Lalonde, AB, B-Lynch, C (eds) A Comprehensive Textbook of Postpartum Hemorrhage, 2nd edn. Sapiens Publishing.Google Scholar

Teig, M, Harkness, M, Catling, S, Clark, V. Survey of cell salvage use in obstetrics in the UK. Poster presentation OAA meeting Sheffield June 2007. International Journal of Obstetric Anesthesia 2007; 16 (Suppl 1): 30.Google Scholar

Teare, KM, Sullivan, IJ, Ralph, CJ. Is cell salvaged vaginal blood loss suitable for re-infusion? International Journal of Obstetric Anesthesia 2015; 24(2): 103–110.CrossRefGoogle ScholarPubMed

Catling, SJ, Williams, S, Fielding, A. Cell salvage in obstetrics: an evaluation of ability of cell salvage combined with leucocyte depletion filter to remove amniotic fluid from operative blood loss at cesarean section. International Journal of Obstetric Anesthesia 1999; 8: 79–84.Google Scholar

Hussain, S, Clyburn, P. Cell salvage-induced hypotension and London buses. Anesthesia 2010; 65(7): 661–663.CrossRefGoogle ScholarPubMed

UK Cell Salvage Action Group. Intraoperative Cell Salvage in Obstetrics. http://transfusionguidelines.org.uk/transfusion-practice/uk-cell-salvage-action-group/technical-factsheets-and-frequently-asked-questions-faq (accessed April 28 2015).Google Scholar

Sullivan, I, Faulds, J, Ralph, C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Cesarean section. British Journal of Anesthesia 2008; 101: 225–229.Google Scholar

Davies, L, Brown, TJ, Haynes, S et al. Cost effectiveness of cell salvage and alternative methods of minimizing perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technology Assessment 2006; 10: 1–228.Google Scholar

Khan, K, Moore, P, Wilson, MJ et al. LB01: Cell Salvage during Caesarean Section: A Randomised Controlled Trial (The SALVO Trial). American Journal of Obstetrics and Gynecology 2017; 216(1): S559 (Abstract).Google Scholar

The Maternal Critical Care Working Group. Providing Equity of Critical and Maternity Care for the Critically Ill Pregnant or Recently Pregnant Woman. https://www.rcoa.ac.uk/system/files/CSQ-ProvEqMatCritCare.pdf (accessed July 24 2017).Google Scholar

Mavrides, E, Allard, S, Chandraharan, E et al. on behalf of the Royal College of Obstetricians and Gynecologists. Postpartum haemorrhage prevention and management. BJOG: An International Journal of Obstetrics and Gynecology 2016 http://onlinelibrary.wiley.com/doi/10.1111/1471–0528.14178/epdf (accessed Feb 21 Feb 2017).Google Scholar

Thomas, D, Wee, M, Clyburn, P et al. Blood transfusion and the anesthetist: Management of massive hemorrhage. Anesthesia 2010; 65: 1153–1161.CrossRefGoogle Scholar

Kenyon, S. Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth. 2007. http://www.nice.org.uk/guidance/cg55/chapter/guidanceCrossRefGoogle Scholar

World Health Organization. WHO Guidelines for the Management of Postpartum Hemorrhage and Retained Placenta; 2009. http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdfGoogle Scholar

Allard, S, Green, L, Hunt, BJ. How we manage the hematological aspects of major obstetric hemorrhage. British Journal of Haematology 2014; 164: 177–188.Google Scholar

Collins, PW, Lilley, G, Bruynseels, D. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014; 124: 585–595.Google Scholar

Collis, RE, Collins, PW. Hemostatic management of obstetric hemorrhage. Anesthesia 2015; 70: 78–86.Google Scholar

Charbit, B, Mandelbrot, L, Samain, E et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Hemostasis 2007; 5: 266–273.CrossRefGoogle ScholarPubMed

De Lloyd, L, Bovington, R, Kaye, A et al. Standard hemostatic tests following major obstetric hemorrhage. International Journal of Obstetric Anesthesia 2011; 20: 135–141.Google Scholar

Thachil, J, Toh, CH. Disseminated intravascular coagulation in obstetric disorders and its acute hematological management. Blood Reviews 2009; 23: 167–176.Google Scholar

Hiippala, ST, Myllyla, GJ, Vahtera, EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia 1995; 81: 360–365.Google Scholar

James, AH, McLintock, C, Lockhart, E. Postpartum hemorrhage: When uterotonics and sutures fail. American Journal of Hematology 2012; 87: S16–S22.CrossRefGoogle ScholarPubMed

Levi, M, Toh, CH, Thachil, J, Watson, HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Journal of Haematology 2009; 145: 24–33.CrossRefGoogle ScholarPubMed

Wada, H, Thachil, J, Di Nisio, M et al. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. Journal of Thrombosis and Haemostasis 2013; 11: 761–767.Google Scholar

Levi, M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thrombosis Research 2013; 131: S32–S34.CrossRefGoogle ScholarPubMed

Bonnar, J, McNicol, GP, Douglas, AS. Coagulation and fibrinolytic mechanisms during and after normal childbirth. BMJ 1970; 2: 200–203.CrossRefGoogle ScholarPubMed

Jones, R, de Lloyd, L, Kealaher, EJ et al. Platelet count and transfuion requirements during moderate or severe postpartum haemorrhage. Anaesthesia 2016; 71: 648–656.CrossRefGoogle ScholarPubMed

Cortet, M, Deneux-Tharaux, C, Dupont, C et al. Association between fibrinogen level and severity of postpartum hemorrhage: Secondary analysis of a prospective trial. British Journal of Anaesthesia 2012; 108: 984–989.Google Scholar

De Lloyd, L, Collins, PW, Kaye, A, Collis, RE. Early fibrinogen as a predictor of red cell requirements during postpartum hemorrhage. International Journal of Obstetric Anesthesia 2012; 21: S13.Google Scholar

Gayat, E, Resche-Rigon, M, Morel, O et al. Predictive factors of advanced interventional procedures in a multicenter severe postpartum hemorrhage study. Intensive Care Medicine 2011; 37: 1816–1825.CrossRefGoogle Scholar

Poujade, O, Zappa, M, Letendre, I, et al. Predictive factors for failure of pelvic arterial embolization for postpartum hemorrhage. International Journal of Gynecology and Obstetrics 2012; 117: 119–123.CrossRefGoogle ScholarPubMed

Solomon, C, Collis, RE, Collins, PW. Hemostatic monitoring during postpartum hemorrhage and implications for management. British Journal of Anesthesia 2012; 109: 851–863.CrossRefGoogle ScholarPubMed

Bell, SF, Rayment, R, Collins, PW, Collis, RE. The use of fibrinogen concentrate to correct hypofibrinogenemia rapidly during obstetric hemorrhage. International Journal of Obstetric Anesthesia 2010; 19: 218–223.Google Scholar

Mackie, IJ, Kitchen, S, Machin, SJ, Lowe, GDO. Guidelines on fibrinogen assays. British Journal of Haematology 2003; 121: 396–404.Google Scholar

De Lange, NM, Lance, MD, De Groot, R, et al. Obstetric hemorrhage and coagulation: An update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstetrical and Gynecological Survey 2012; 67: 426–435.Google Scholar

Hill, JS, Devenie, G, Powell, M. Point-of-care testing of coagulation and fibrinolytic status during postpartum hemorrhage: Developing a thrombelastography©-guided transfusion algorithm. Anesthesia and Intensive Care 2012; 40: 1007–1015.CrossRefGoogle ScholarPubMed

Raza, I, Davenport, R, Rourke, C et al. The incidence and magnitude of fibrinolytic activation in trauma patients. Journal of Thrombosis and Haemostasis 2013; 11: 307–314.Google Scholar

Afshari, A, Wikkelso, A, Brok, J, Moller, AM, Wetterslev, J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor hemotherapy versus usual care in patients with massive transfusion. Cochrane Database of Systematic Reviews 2011; (3): CD007871.Google Scholar

Mallaiah, S, Barclay, P, Harrod, I, Chevannes, C, Bhalla, A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric hemorrhage. Anesthesia 2015; 70: 166–175.CrossRefGoogle Scholar

Huissoud, C, Carrabin, N, Audibert, F et al. Bedside assessment of fibrinogen level in postpartum hemorrhage by thrombelastometry. BJOG: An International Journal of Obstetrics and Gynecology 2009; 116: 1097–1102.Google Scholar

Van Rheenen-Flach, LE, Zweegman, S, Boersma, F et al. A prospective longitudinal study on rotation thromboelastometry in women with uncomplicated pregnancies and postpartum. Australian and New Zealand Journal of Obstetrics and Gynaecology 2013; 53: 32–36.Google Scholar

Pavord, S, Maybury, H. How I treat postpartum hemorrhage. Blood 2015; 125: 2759–2770.Google Scholar

Wikkelsoe, AJ, Edwards, HM, Afshari, A et al. Pre-emptive treatment with fibrinogen concentrate for postpartum hemorrhage: randomized controlled trial. British Journal of Anesthesia 2015; 114: 623–633.Google Scholar

Ahmed, S, Harrity, C, Johnson, S et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric hemorrhage – an observational study. Transfusion Medicine 2012; 22: 344–349.CrossRefGoogle ScholarPubMed

Gollop, ND, Chilcott, J, Benton, A et al. National audit of the use of fibrinogen concentrate to correct hypofibrinogenemia. Transfusion Medicine 2012; 22: 350–355.Google Scholar

Weinkove, R, Rangarajan, S. Fibrinogen concentrate for acquired hypofibrinogenemic states. Transfusion Medicine 2008; 18: 151–157.CrossRefGoogle Scholar

Shields, LE, Smalarz, K, Reffigee, L et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. American Journal of Obstetrics and Gynecology 2011; 205: 368.CrossRefGoogle Scholar

Shields, LE, Wiesner, S, Fulton, J, Pelletreau, B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. American Journal of Obstetrics and Gynecology 2015; 212: 272–280.Google Scholar

Teofili, L, Bianchi, M, Zanfini, BA et al. Acute lung injury complicating blood transfusion in post-partum hemorrhage: Incidence and risk factors. Mediterranean Journal of Hematology and Infectious Diseases 2014; 6: e2014.069.Google Scholar

Collins, PW, Solomon, C, Sutor, K et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. British Journal of Anaesthesia 2014; 113: 585–595.CrossRefGoogle ScholarPubMed

Collins, PW, Kadir, R, Thachil, J. Management of coagulopathy associated with postpartum haemorrhage: guidance from the SSC of ISTH. Journal of Thrombosis and Haemostasis 2016; 14: 205–210.Google Scholar

Chowdhury, P, Saayman, AG, Paulus, U, Findlay, GP, Collins, PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of hemostasis in critically ill patients. British Journal of Haematology 2004; 125: 69–73.CrossRefGoogle Scholar

CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–1101.Google Scholar

Novikova, N, Hofmeyr, GL. Tranexamic acid for preventing postpartum hemorrhage. Cochrane Database of Systematic Reviews 2010; (7): CD007872.Google Scholar

Ferrer, P, Roberts, I, Sydenham, E, Blackhall, K, Shakur, H. Anti-fibrinolytic agents in postpartum hemorrhage: A systematic review. BMC Pregnancy Childbirth 2009; 9: 29.Google Scholar

Ducloy-Bouthors, AS, Jude, B, Duhamel, A et al. High-dose tranexamic acid reduces blood loss in postpartum hemorrhage. Critical Care 2011; 15: R117.CrossRefGoogle Scholar

Gungorduk, K, Yildirim, G, Asicioglu, O et al. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: A prospective, randomized, double-blind, placebo-controlled study. American Journal of Perinatology 2011; 28: 233–239.Google Scholar

WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389: 2105–2116.CrossRefGoogle Scholar

Alfirevic, Z, Elbourne, D, Pavord, S et al. Use of recombinant activated factor vii in primary postpartum hemorrhage: The northern European registry 2000–2004. Obstetrics and Gynecology 2007; 110: 1270–1278.Google Scholar

Franchini, M, Franchi, M, Bergamini, V et al. The use of recombinant activated FVII in postpartum hemorrhage. Clinical Obstetrics and Gynecology 2010; 53: 219–227.CrossRefGoogle ScholarPubMed

Levi, M, Levy, JH, Andersen, HF, Truloff, D. Safety of recombinant activated factor VII in randomized clinical trials. New England Journal of Medicine 2010; 363: 1791–1800.CrossRefGoogle ScholarPubMed

Lavigne-Lissalde, G. Recombinant human factor VIIa for reducing the need for invasive second line therapies in severe refactory postpartum hemorrhage: A multicenter, randomised open controlled study. Journal of Thrombosis and Hemostasis 2015; 13: 520–529.Google Scholar

World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Hemorrhage. Geneva: WHO; 2012.Google Scholar

Healthcare Commission. Investigation into 10 Maternal Deaths at, or Following Delivery at, Northwick Park Hospital, North West London Hospitals NHS Trust, Between April 2002 and April 2005. London: Commission for Healthcare Audit and Inspection; 2006.Google Scholar

Royal College of Obstetricians and Gynecologists. Postpartum Hemorrhage, Prevention and Management. Green-Top Guideline No. 52. London: Royal College of Obstetricians and Gynecologists; 2011.Google Scholar

Royal College of Obstetricians and Gynecologists. The Role of Emergency and Elective Interventional Radiology in Postpartum Hemorrhage (Good Practice No. 6). London: RCOG; 2007.Google Scholar

Silver, RM, Barbour, KD. Placenta accreta spectrum: accreta, increta, and percreta. Obstetrics and Gynecology Clinics of North America 2015; 42(2): 381–402.Google Scholar

Royal College of Obstetricians and Gynecologists. Placenta Previa and Placenta Previa Accreta: Diagnosis and Management. Green-Top Guideline No. 27. London: Royal College of Obstetricians and Gynecologists; 2005.Google Scholar

Gipson, MG, Smith, MT. Endovascular therapies for primary postpartum hemorrhage: techniques and outcomes. Seminars in Interventional Radiology 2013; 30(4): 333–339.Google Scholar

Lee, HY, Shin, JH, Kim, J et al. Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution. Radiology 2012; 264(3): 903–909.CrossRefGoogle ScholarPubMed

Kim, YJ, Yoon, CJ, Seong, NJ et al. Failed pelvic arterial embolization for postpartum hemorrhage: clinical outcomes and predictive factors. Journal of Vascular and Interventional Radiology 2013; 24(5): 703–709.CrossRefGoogle ScholarPubMed

Ballas, J, Hull, AD, Senz, C et al. Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradox. American Journal of Obstetrics and Gynecology 2012; 207(3): 216.e1–5.CrossRefGoogle ScholarPubMed

Cali, G, Forlani, F, Giambanco, L et al. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. European Journal of Obstetrics & Gynecology and Reproductive Biology 2014; 179: 36–41.CrossRefGoogle ScholarPubMed

Pavord, S, Rayment, R, Madan, B et al. The Management of Inherited Bleeding Disorders in Pregnancy. RCOG Green-Top Guideline No. 71; 2017. http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14592/epdfGoogle Scholar

Abildgaard, CF, Suzuki, Z, Harrison, J et al. Serial studies in von Willebrand’s disease: variability versus “variants”. Blood 1980; 56(4): 712–716.CrossRefGoogle ScholarPubMed

Sadler, JE, Budde, U, Eikenboom, JC et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis 2006; 4(10): 2103–2114.Google Scholar

Rydz, N, James, PD. The evolution and value of bleeding assessment tools. Journal of Thrombosis and Haemostasis 2012; 10(11): 2223–2229.CrossRefGoogle ScholarPubMed

Rodeghiero, F, Tosetto, A, Abshire, T et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. Journal of Thrombosis and Haemostasis 2010; 8(9): 2063–2065.Google Scholar

Laffan, MA, Lester, W, O’Donnell, JS et al. The diagnosis and management of von Willebrand disease: a United Kingdom Hemophilia Center Doctors Organization guideline approved by the British Committee for Standards in Hematology. British Journal of Haematology 2014; 167(4): 453–465.CrossRefGoogle Scholar

James, PD, Paterson, AD, Notley, C et al. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study. Journal of Thrombosis and Haemostasis 2006; 4(4): 783–792.Google Scholar

Eikenboom, J, Van Marion, V, Putter, H et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. Journal of Thrombosis and Haemostasis 2006; 4(4): 774–782.Google Scholar

Stirling, Y, Woolf, L, North, WR et al. Hemostasis in normal pregnancy. Thrombosis and Haemostasis 1984; 52(2): 176–182.Google Scholar

Sanchez-Luceros, A, Meschengieser, SS, Marchese, C et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagulation and Fibrinolysis 2003; 14: 647–651.CrossRefGoogle ScholarPubMed

Ranger, A, Manning, RA, Lyall, H et al. Pregnancy in type 2B VWD: a case series. Hemophilia 2012; 18(3): 406–412.CrossRefGoogle ScholarPubMed

James, AH, Jamison, MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. Journal of Thrombosis and Haemostasis 2007; 5: 1165–1169.CrossRefGoogle ScholarPubMed

Ray, JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstetrical & Gynecological Survey 1998; 53(7): 450–455.Google Scholar

Trigg, DE, Stergiotou, I, Peitsidis, P et al. A systematic review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Hemophilia 2012; 18(1): 25–33.Google Scholar

Mannucci, PM, Tenconi, PM, Castaman, G, Rodeghiero, F. Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. Blood 1992; 79: 3130–3137.CrossRefGoogle ScholarPubMed

Huq, FY, Kulkarni, A, Agbim, EC et al. Changes in the levels of factor VIII and von Willebrand factor in the puerperium. Hemophilia 2012; 18: 241–245.Google Scholar

Roqué, H, Funai, E, Lockwood, CJ. von Willebrand disease and pregnancy. The Journal of Maternal–Fetal Medicine 2000; 9: 257–266.Google ScholarPubMed

Lentaigne, CE, Sodhi, V, Usman, N, McCarthy, A, Millar, CM. Hemostatic management of pregnant women with platelet function disorders: utility of PFA-100. Journal of Thrombosis and Haemostasis 2013; 11: 1152.Google Scholar

Pavord, S, Rayment, R, Madan, B et al. The management of inherited bleeding disorders in pregnancy. RCOG Green-Top Guideline No. 71. April 2017 http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14592/epdf (accessed July 25 2017).Google Scholar

Plug, I, Mauser-Bunschoten, EP, Bröcker-Vriends, AH et al. Bleeding in carriers of hemophilia. Blood 2006; 108(1): 52–56.Google Scholar

Miesbach, W, Alesci, S, Geisen, C, Oldenburg, J. Association between phenotype and genotype in carriers of hemophilia A. Hemophilia 2011; 17(2): 246–251.CrossRefGoogle Scholar

Kulkarni, R, Lusher, JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. Journal of Pediatric Hematology/Oncology 1999; 21: 289–295.Google Scholar

Kadir, RA, Economides, DL, Braithwaite, J, Goldman, E, Lee, CA. The obstetric experience of carriers of hemophilia. British Journal of Obstetrics and Gynecology 1997; 104: 803–810.Google Scholar

Letsky, EA. Hemostasis and epidural anesthesia. International Journal of Obstetric Anesthesia 1991; 1: 51–54.Google Scholar

Lee, CA, Chi, C, Pavord, SR et al. UK Hemophilia Center Doctors’ Organization. The obstetric and gynecological management of women with inherited bleeding disorders: review with guidelines produced by a taskforce of UK Hemophilia Center Doctors’ organization. Hemophilia 2006; 12: 301–336.Google Scholar

Asakai, R, Chung, DW, Davie, EW, Seligsohn, U. Factor XI deficiency in Ashkenazi Jews in Israel. New England Journal of Medicine 1991; 325: 153–158.Google Scholar

Hancock, JF, Wieland, K, Pugh, RE et al. A molecular genetic study of factor XI deficiency. Blood 1991; 77: 1942–1948.Google Scholar

Bolton-Maggs, PH, Patterson, DA, Wensley, RT, Tuddenham, EG. Definition of the bleeding tendency in factor XI-deficient kindreds – a clinical and laboratory study. Thrombosis and Haemostasis 1995; 73: 194–202.Google ScholarPubMed

Bolton-Maggs, PH, Wan-Yin, BY, McCraw, AH, Slack, J, Kernoff, P. Inheritance and bleeding in factor XI deficiency. British Journal of Haematology 2008; 69: 521–528.Google Scholar

Myers, B, Pavord, S, Kean, L, Hill, M, Dolan, G. Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal hemorrhage in 33 women with Factor XI deficiency. BJOG: an International Journal of Obstetrics and Gynecology 2008; 114: 643–646.Google Scholar

Kadir, RA, Lee, CA, Sabin, CA, Pollard, D, Economides, DL. Pregnancy in women with von Willebrand’s disease or factor XI deficiency. British Journal of Obstetrics and Gynaecology 1998; 105: 314–321.Google Scholar

Bolton-Maggs, PH, Perry, DJ, Chalmers, EA et al. The rare coagulation disorders – review with guidelines for management from the United Kingdom Hemophilia Center Doctors’ Organization. Hemophilia 2004; 10: 593–628.Google Scholar

Bolton-Maggs, PH, Colvin, BT, Satchi, BT et al. Thrombogenic potential of factor XI concentrate. Lancet 1994; 344: 748–749.CrossRefGoogle ScholarPubMed

Salomon, O, Steinberg, DM, Tamarin, I, Zivelin, A, Seligsohn, U. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagulation and Fibrinolysis 2005; 16: 37–41.Google Scholar

Kadir, R, Chi, C, Bolton-Maggs, P. Pregnancy and rare bleeding disorders. Hemophilia 2009; 15(5): 990–1005.CrossRefGoogle ScholarPubMed

Mumford, AD, Ackroyd, S, Alikhan, R, et al. and the BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders. British Journal of Haematology 2014; 167: 304–326.Google Scholar

Sharief, LAT, Kadir, RA. Congenital factor XIII deficiency in women: a systematic review of literature. Hemophilia 2013; 19(6):e349–e357.CrossRefGoogle ScholarPubMed

Asahina, T, Kobayashi, T, Takeuchi, K et al. Blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstetrical & Gynecological Survey 2007; 62: 255–260.CrossRefGoogle ScholarPubMed

Kobayashi, T, Kanayama, N, Tokunaga, N et al. Prenatal and peripartum management of congenital afibrinogenemia. British Journal of Haematology 2000; 109: 364–366.Google Scholar

Haverkate, F, Samama, M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thrombosis and Hemostasis 1995; 73: 151–161.Google ScholarPubMed

Chi, C, Kadir, R. Inherited bleeding disorders in pregnancy. Best Practice and Research Clinical Obstetrics and Gynecology 2012; 26: 103–117.CrossRefGoogle ScholarPubMed

Kadir, R, Chi, C, Bolton-Maggs, P. Pregnancy and rare bleeding disorders. Hemophilia 2009; 15: 990–1005.CrossRefGoogle ScholarPubMed

Ludlam, CA, Pasi, KJ, Bolton-Maggs, P et al. A framework for genetic service provision for hemophilia and other inherited bleeding disorders. Hemophilia 2005; 11: 145–163.Google Scholar

Miller, R. Genetic Counseling for Hemophilia. World Federation of Hemophilia; 2002. www.wfh.orgGoogle Scholar

Kasper, CK, Lin, JC. Prevalence of sporadic and familial hemophilia. Hemophilia 2007; 13: 90–92.Google Scholar

Plug, I, Mauser-Bunschoten, EP, Broker-Vriends, AH et al. Bleeding in carriers of hemophilia. Blood 2006; 108: 52–56.Google Scholar

Shetty, S, Ghosh, K, Pathare, A, Mohanty, D. Carrier detection in hemophilia A families: comparison of conventional coagulation parameters with DNA polymorphism analysis – first report from India. Hemophilia 2001; 5: 243–246.Google Scholar

Keeney, S, Mitchell, M, Goodeve, A; on behalf of the UK Haemophilia Centre Doctors’ Organisation (UKHCDO), the Haemophilia Genetics Laboratory Network and the Clinical Molecular Genetics Society. Practice Guidelines for the Molecular Diagnosis of Haemophilia A; 2010. http://www.acgs.uk.com/media/774613/haemophilia_a_bpg_revision_sept_2011_approved.pdfGoogle Scholar

Mitchell, M, Keeney, S, Goodeve, A; on behalf of the UK Haemophilia Centre Doctors’ Organisation (UKHCDO), the Haemophilia Genetics Laboratory Network and the Clinical Molecular Genetics Society. Practice Guidelines for the Molecular Diagnosis of Haemophilia B; 2010. http://www.acgs.uk.com/media/774631/haemophilia_b_bpg_revision_sept_2011_approved.pdfGoogle Scholar

Kessler, L, Adams, R, Mighion, L et al. Prenatal diagnosis in hemophilia A: experience of the genetic diagnostic laboratory. Hemophilia 2014; 20: e384–391.Google Scholar

Rallapalli, PM, Kemball-Cook, G, Tuddenham, EG et al. An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B. Journal of Thrombosis and Haemostasis 2013; 11: 1329–1340.Google Scholar

Payne, AB, Bean, CJ, Hooper, WC, Miller, CH. Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening. Journal of Thrombosis and Haemostasis 2012; 10: 1951–1954.Google Scholar

Leuger, M, Oldenburg, J Lavergne, J-M et al. Somatic mosaicism in hemophilia A: a fairly common event. American Journal of Human Genetics 2001; 69: 75–87.CrossRefGoogle Scholar

Green, PM, Saad, S, Lewis, CM, Gianelli, F. Mutation rates in humans I: overall and sex-specific rates obtained from a population study of hemophilia B. American Journal of Human Genetics 1999; 65: 1572–1579.CrossRefGoogle ScholarPubMed

Lee, C, Chi, C, Pavord, SR et al. The obstetric and gynecological management of women with inherited bleeding disorders – review of guidelines produced by a taskforce of UK Hemophilia Center Doctors’ Organization. Hemophilia 2006; 12: 301–336.Google Scholar

Lewis, C, Hill, M, Skirton, H, Chitty, LS. Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users’ perspective. European Journal of Human Genetics 2012; 20: 1127–1133.Google Scholar

Colmant, C, Morin-Surroca, M, Fuchs, F et al. Non-invasive prenatal testing for fetal sex determination: is ultrasound still relevant? European Journal of Obstetrics & Gynecology and Reproductive Biology 2013; 171: 197–204.Google Scholar

Avent, N, Chitty, LS. Non-invasive diagnosis of fetal sex; utilization of free fetal DNA in maternal plasma and ultrasound. Prenatal Diagnosis 2006; 26: 598–603.Google Scholar

Bustamente-Aragones, A, Rodriguez de Alba, M, Gonzalez-Gonzalez, C et al. Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing hemophilia in the foetuses of female carriers. Hemophilia 2008; 14: 593–598.CrossRefGoogle Scholar

RCOG. Amniocentesis and Chorionic Villous Sampling. Green-Top Guideline No. 8. London: Royal College of Obstetricians and Gynecologists; 2010. http://www.rcog.org.uk/Google Scholar

Alfirevic, Z, Mujezinovic, F, Sundberg, K. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database of Systematic Reviews 2003 (3): CD003252.Google Scholar

Cutler, J, Chappell, LC, Kyle, P, Madan, B. Third trimester amniocentesis for diagnosis of inherited bleeding disorders prior to delivery. Hemophilia 2013; 19: 904–907.Google Scholar

Peyvandi, F, Garagiola, I, Mortarino, M. Prenatal diagnosis and preimplantation genetic diagnosis: novel technologies and state of the art of PGD in different regions of the world. Hemophilia 2011; 17 (Suppl 1): 14–17.Google Scholar

Michelidis, K, Tuddenham, EG, Turner, C et al. Live birth following the first mutation specific pre-implantation genetic diagnosis for hemophilia A. Thrombosis and Hemostasis 2006; 95: 373–379.Google Scholar

Tsui, NBY, Kadir, RA, Chan, KC et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011; 117: 3684–3691.Google Scholar